Waldemar Rastawicki Selected Research

enterobacterial common antigen

1/2007	[Humoral response to selected antigens of Yersinia enterocolitica and Yersinia pseudotuberculosis in the course of yersiniosis in humans. I. Occurrence of antibodies to enterobacterial common antigen (ECA)].
1/2005	[The role of Salmonella and Yersinia in the pathogenesis of spondyloarthropathies and rheumatoid arthritis. I. Detection of bacteria, bacterial DNA, lipopolysaccharide and ECA antigen in synovial fluid or blood].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Waldemar Rastawicki Research Topics

Disease

18	Infections 10/2021 - 01/2006
11	Yersinia Infections 01/2016 - 01/2002
6	Tularemia 03/2018 - 01/2005
4	Whooping Cough (Pertussis) 10/2021 - 01/2010
4	Reactive Arthritis (Reiter Disease) 01/2014 - 01/2004
3	Respiratory Tract Infections (Respiratory Tract Infection) 01/2012 - 01/2002
3	Arthritis (Polyarthritis) 01/2006 - 01/2005
2	COVID-19 01/2021 - 01/2020
2	Bacterial Infections (Bacterial Infection) 01/2016 - 01/2009
2	Legionnaires' Disease (Legionnaire's Disease) 01/2015 - 01/2010
2	Campylobacter Infections (Campylobacter Infection) 01/2008 - 01/2007
2	Abdominal Pain (Pain, Abdominal) 01/2007 - 01/2006
1	Surgical Wound 03/2022
1	Coinfection 03/2018
1	Typhoid Fever (Typhoid) 01/2015
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 01/2014
1	Diphtheria 11/2013
1	Chronic Cough 01/2012
1	Rhinoscleroma 01/2010
1	Graves Disease (Basedow Disease) 01/2008
1	Gastroenteritis 01/2007
1	Rheumatoid Arthritis 01/2005
1	Spondylarthropathies 01/2005
1	Enterocolitis 01/2002
1	Sepsis (Septicemia) 01/2002

Drug/Important Bio-Agent (IBA)

28	AntibodiesIBA 10/2021 - 01/2004
19	Immunoglobulin G (IgG)IBA 09/2021 - 01/2002
18	AntigensIBA 01/2021 - 01/2004
16	Immunoglobulin A (IgA)IBA 01/2020 - 01/2004
15	Immunoglobulin M (IgM)IBA 01/2020 - 01/2002
12	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2003
6	ImmunosorbentsIBA 01/2015 - 01/2005
6	EnzymesIBA 01/2015 - 01/2005
6	LipopolysaccharidesIBA 01/2015 - 01/2004
5	Anti-Bacterial Agents (Antibiotics)IBA 03/2022 - 01/2002
5	Immunoglobulins (Immunoglobulin)IBA 01/2014 - 01/2006
4	Pertussis ToxinIBA 10/2021 - 01/2009
4	Recombinant ProteinsIBA 01/2016 - 01/2009
3	LatexIBA 01/2017 - 01/2002
2	VaccinesIBA 10/2021 - 01/2021
2	enterobacterial common antigenIBA 01/2007 - 01/2005
1	Acellular VaccinesIBA 10/2021
1	Viral AntigensIBA 01/2020
1	Polysaccharides (Glycans)IBA 01/2015
1	Immunoglobulin IsotypesIBA 01/2014
1	coomassie Brilliant BlueIBA 01/2014
1	Diphtheria ToxinIBA 11/2013
1	Hemagglutinins (Hemagglutinin)IBA 01/2013
1	Virulence Factors (Pathogenicity Factors)IBA 01/2013
1	Plasmodium serine repeat antigenIBA 01/2010
1	Lipoproteins (Lipoprotein)IBA 01/2009
1	AS 115IBA 01/2007
1	Biological Warfare AgentsIBA 01/2006
1	DNA (Deoxyribonucleic Acid)IBA 01/2005
1	Bacterial DNAIBA 01/2005
1	Complement System Proteins (Complement)IBA 01/2002

Therapy/Procedure

1	Therapeutics 03/2022
1	Microspheres (Microsphere) 05/2015